chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt came to office on 04/26/2002 and was diagnosed with abscess and started on Keflex x 10d.
Patient reported her throat felt itchy and a little sore. Vitals stable, slightly hypertensive but patient has hypertension and skipped her meds this morning. She usually takes loratadine, lisinopril, atenolol. She was given 10mg of sublingual Zyrtec. Patient wanted to leave facility. Doctor assessed patient, no wheezing, no worsening of symptoms. Patient ambulated home with son and said she would use her epi-pen at home if needed.
Around August 1st, I felt like I had a head cold. It got worse, breathing problems. I had a CXR. I used inhaler. Slept often, I was weak. I went in to see my doctor. I was given medication started feeling worse. Went back in for shot, still didn't feel better. I went back and was given Zpak antibiotics and prednisone. It was then that I began to feel better. It took a long time to build up strength just to walk outside. Tested twice negative for Covid. Doctor stated he felt that I did have Covid and treated me accordingly.
Fever, chills, nausea, aches, headaches. Began morning after vaccination and persisted for 24 hours
pt recv vax 7NOV96 & 8NOV96 pt devel a severe rxn involving cellulitis of the upper arm;pt cellulitis persisted;
Initial medication error report received on 04 October 2013 from a nurse. A 65 years old unknown patient whose gender, medical history and concomitant medications were not reported, received a dose of FLUZONE ID (route, lot number and site of vaccination was not reported) on an unspecified date. We administered to a 65 year old patient. List of documents held by sender: none.
I contracted COVID-19- positive  one week after having the vaccine; I had a runny nose and a little tired and mild congestion also I was feeling week; headache and I was constipated
This medically confirmed non-serious report (initial receipt 17-AUG-2014) concerns a 21-year old female patient. On 16 AUG-2014, The patient received AFLURIA injection (batch number T57205).  On 16-APR-2014, after vaccination, the patient experienced neuralgia. The patient was still experiencing neuralgia on the left side of the face. She also developed left arm tingling and some numbness of her  neck. The outcome was reported as not yet recovered.
At 3 wks. post vaccination he found unusual bumps in clumps on face. He was very ill after both shots (aches all over body, fever, sore arm). A couple of weeks later I had the same weird bumps with intense itching and sweats and widespread bumps all over my body. 6 mo. later we still have this "moluscum". I talked with a dental hygienist who told me a lady she recently saw got shingles in the mouth from this vaccine. The stress of not getting a diagnosis or treatment (none known) plus cosmetic self consciousness and the sweats and itching are terrible. This is a bad vaccine. I have had a cortisone shot for this with no improvement. We have used antibiotic cream, essential oils, fungus cream and retina and still no improvement. We have suffered for 6 months.
Patient received the Pfizer vaccine at 2:28, patient waited in observation area. At 2:38 patient reported feeling a scratchy throat. Patient was given 25mg of oral Benadryl, no other medications were given by staff. Patient then reported having an allergic reaction to bees in the past. After 15 minutes patient reported feeling dizzy, she had not eaten prior to receiving vaccination and had worked night shift with only a few hours of sleep. Patient was given a bottle of water and pouch of fruit snacks. After 25-30 minutes patient reported the scratchy feeling still in throat and difficulty swallowing. 911 was called. After 40 minutes patient walked out of pharmacy with EMTs.
Lost use of legs after the second dose of the Covid Vaccine; Very weak after second dose of the Covid Vaccine; Blood Pressure has dropped drastically (90's systolic and 40's diastolic); Kidney problem requiring antibiotics; Trouble comprehending, loss of focus; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: ER8734), dose 2 via an unspecified route of administration, administered in the left arm on 09Apr2021 (at the age of 73 years old) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. No family medical history relevant to AE. No illness at time of vaccination. The patient concomitant medication was not reported. No other vaccines were given within 4 weeks. The patient previously took Bactrim and experienced urticaria. Patient also received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6208), dose 1 via an unspecified route of administration, administered in the left arm on 19Mar2021 as dose 1, single for COVID-19 immunization. No additional vaccines were administered on same date of the Pfizer suspect. On unspecified date of Apr2021, the patient experienced lost use of legs after the second dose of the covid vaccine, very weak after second dose of the covid vaccine, blood pressure has dropped drastically, kidney problem requiring antibiotics and on an unspecified date of 2021 the patient had trouble comprehending, loss of focus. All events resulted to physician office visit but not emergency room. The patient underwent lab tests and procedures which included blood pressure resulted 40/90 mmHg on unspecified date of Apr2021 (dropped drastically), blood test with lab work for her kidneys and blood work done on unspecified date of Apr2021. Therapeutic measures were taken as a result of kidney problem requiring antibiotics. Reporter states she thinks it should be noted that the vaccine can cause heart problems. States the vaccine can do more than what they are saying it can do, states it can kill a person and she had no symptoms before the vaccines. The clinical outcome of the events blood pressure has dropped drastically, kidney problem requiring antibiotics was reported as unknown, lost use of legs after the second dose of the covid vaccine, very weak after second dose of the covid vaccine was reported as not recovered, trouble comprehending, loss of focus was reported as recovering.  No follow-up attempts are needed. No further information is expected.
allergy sneezing attack; flushing in face/flush in the face/flush in the face and it's very red and swollen; flush in the face and it's very red and swollen; allergy sneezing attack; Headache; Aches and pain; Fever; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number requested), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history was not reported.  Concomitant medication included diphenhydramine hydrochloride (BENADRYL). It was reported that the patient had the Pfizer COVID vaccine and have had reactions (unspecified) to other medicines (unspecified medication) so the patient stayed (as reported) for about half an hour and did fine but about half an hour later on the way home the patient started getting flushing in face and like an allergy sneezing attack and then when the got home the patient got a headache and noted fever and the aches and pain are normal but had a flush in the face and it's very red and swollen. The patient wanted to know before going for the second one, can he/she take Benadryl because the patient stated that he/she took Benadryl when he/she came home. The outcome of the events was unknown.   Information on Batch/Lot number was requested.
Headache 30 minutes after receiving vaccine, no previous history of migraines, patient admitted to not having eaten prior to coming to his appointment that morning. He was seen in the ED, glucose and CMP was normal, given the timing and association of the headache with new vaccine administration, concern for subarachnoid hemorrhage was low, headache was treated and improved following TYLENOL and food (he was given a turkey sandwich to eat).
pt recvd vax 27OCT95 p/DPH & had h/a 2-3 hrs & felt bad;
On 02/07/2021, my arm swelled to the size of an large orange.  It was red,  hot, swollen, and  tender.  I would sweat profusely if I walked more than 3 steps.  I had a bad headache and I developed ringing in my ear and I was nauseated. It went on for like a week. I was also getting pain in my chest.  I continued to have sweating in the night,  and sweating for every  2 steps  I would take, but I was able to function. The ringing in my ear did not go away. The doctor eventually sent me for a hearing test. It has not gotten better it is still there. Occasionally,  I still get chest pain. after my 3rd shot I felt pretty sick. but it was not as bad as the 2nd time.  I could not hear anything  because the ringing was too loud in my ear. The diagnosis was high frequency sensorineural hearing loss both sides.
Per Dr., pt was prescribed PENTACEL immunization, two-part vaccine not properly prepared, sterile diluent utilized instead of vaccine specific diluent. Dr., pediatrics lead, direct supervisor, and floor manager, notified of medication error. Per Dr., pt at no risk of ASE and needs to be revaccinated with PENTACEL.
THE PATIENT RECEIVED A JOHNSON AND JOHNSON COVID-19  BOOSTER SHOT ON 1/7/2022. PER PT, SHE HAS BEEN HAVING NUMBNESS ON HER LEFT ARM EVER SINCE SHE GOT THE SHOT. SHE SAID SHE WAS  TOTALLY FINE WITH HER FIRST JOHNSON AND JOHNSON COVID-19 VACCINE, WHICH SHE RECEIVED ON 9/1/2021 AT OUR PHARMACY. SHE REPORTED THAT SHE HAD MUSCLE ACHE ON HER NECK AND SHOULDER FOR THE FIRST 3 DAYS. NOW SHE STILL HAS NUMBNESS ON HER LEFT ARM THAT HAS BEEN GETTING BETTER LITTLE BY LITTLE. PER PT, HER DOCTOR TOLD HER TO WAIT FOR HER SYMPTOMS GO AWAY ON 2/15/2022.
Information has been received from a health professional concerning an approximately 3 year old male who in 2003 was vaccinated SC with a first dose of varicella virus vaccine live (Oka/Merck). On approximately 06-MAR-2007, "earlier in the week" the patient presented to the doctor office with a case of breakthrough chicken pox of more thatn 50 lesions. The patient is recovering. Additional information has been requested.
There was rash was all over the body/it was red in color; Little dry skin; This is a spontaneous report from a contactable physician. An 87-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6201; Expiration Date: Jul2021), via an unspecified route of administration, administered in left arm (reported left shoulder) on 21Feb2021 (at 87 years old) as dose 2, single for COVID-19 immunization. Medical history included colon cancer. There were no concomitant medications. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9261), on 30Jan2021 (at 87 years old), for COVID-19 immunization. It was reported that after the patient came home on 21Feb2021, the rash was all over the body. He wanted to know what he should do. He has little dry skin, no fever, no pain, no headache. He got the rash on Sunday, 21Feb2021, and went there, it was so cold there, that his whole body was covered, and so he did not see the rash till he went to bed at night on Monday. The was rash was all over the body, there was no temperature when touching it, it was red in color, there was no texture when looking at it, the skin appeared smooth, however his skin was a little dry. The patient underwent blood tests which were all normal on an unknown date. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Bruising of arm; This non-serious case was reported by a consumer and described the occurrence of bruising of arm in a 50-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced bruising of arm (Verbatim: Bruising of arm). The outcome of the bruising of arm was not resolved.   It was unknown if the reporter considered the bruising of arm to be related to Shingles vaccine.     It was unknown if the company considered the bruising of arm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 01-JUN-2023 The reporter was a caregiver. At the time of reporting, the symptoms were not treated. The reporter did not give consent to contact.
deep tissue redness and about a 3x3cm abscess/lump underneath the skin at the injection site/ very painful to touch/ Redness, swelling, tenderness, and lump/abscess under skin at the injection site; Initial information received on 07-May-2019 regarding an unsolicited valid non-serious case received from a consumer or non healthcare professional via phone and additional information was received on 07-May-2019.  This case involves a 44 years old female patient who experienced deep tissue redness and about a 3x3cm abscess/lump underneath the skin at the injection site/ very painful to touch/ redness, swelling, tenderness, and lump/abscess under skin at the injection site, while she received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past vaccination(s) included ADACEL and developed local reaction.  The patient's past medical history, medical treatment(s), family history and concomitant medications were not provided.   On 16-Apr-2019, the patient received a booster dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot number: U6217AA and expiry date not reported) via intramuscular route in the left deltoid.  On an unknown date, the patient developed a non-serious deep tissue redness and about a 3x3cm abscess/lump underneath the skin at the injection site/ very painful to touch/ redness, swelling, tenderness, and lump/abscess under skin at the injection site (vaccination site inflammation) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  No Lab data was reported.  Final diagnosis was deep tissue redness and about a 3x3cm abscess/lump underneath the skin at the injection site/ very painful to touch/ redness, swelling, tenderness, and lump/abscess under skin at the injection site.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Not Recovered / Not Resolved on an unknown date for deep tissue redness and about a 3x3cm abscess/lump underneath the skin at the injection site/ very painful to touch/ redness, swelling, tenderness, and lump/abscess under skin at the injection site.  Documents held by the sender: none.
She said that she started to have a headache, fever, and nausea. She also said that her shoulder hurt quite bad. She said she was shaking.  She said she thought she was shaking from the pain in her shoulder.
Feels hot and cold; Injected arm is stiff; headache; Body aches all over; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (hot and cold), MUSCULOSKELETAL STIFFNESS (Injected arm is stiff), HEADACHE, and MYALGIA in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0481A21A and 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (Feels hot and cold), MUSCULOSKELETAL STIFFNESS (Injected arm is stiff), HEADACHE, and MYALGIA. At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (Feels hot and cold), MUSCULOSKELETAL STIFFNESS (Injected arm is stiff), HEADACHE, and MYALGIA outcome was unknown.            No concomitant and treatment medications were provided. Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-097518.
Drug interaction: Hypoprothrombinemia. Pt had received influenza vaccine 1 week earlier; INR was therapeutic before influenza vaccine. DX: elevated prothrombin time due to flu vaccine administration (probable). Treatment: Warfarin hold until INR decreased. Diagnosed with interaction between warfarin and influenza vaccine.
Thursday soon after booster: Tingling above lip and then around left side of face where have residual shingles nerve irritation (from 10 years ago).  Saturday felt generally unwell with upset stomach.
There was a miscommunication on which vaccine the patient wanted. Patient stated they needed their 2nd shot. The staff member entering the patients info took this to mean their 2nd overall dose, but patient was needing their 2nd booster -the new bivalent-. This wasn't noticed until after the shot was given. The patient did not have any adverse reactions, but was upset they have to come back in two months to get the Bivalent shot.
The vial was out of the fridge for over 12 hours; Given a second shot of 0.25ml of a vial taken out of the fridge; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vial was out of the fridge for over 12 hours) and EXTRA DOSE ADMINISTERED (Given a second shot of 0.25ml of a vial taken out of the fridge) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 ml. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vial was out of the fridge for over 12 hours) and EXTRA DOSE ADMINISTERED (Given a second shot of 0.25ml of a vial taken out of the fridge). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vial was out of the fridge for over 12 hours) and EXTRA DOSE ADMINISTERED (Given a second shot of 0.25ml of a vial taken out of the fridge) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.
very sick; dizziness; upset stomach; severe headache; chills; on a heating pad but his temperature is normal; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick), DIZZINESS (dizziness), ABDOMINAL DISCOMFORT (upset stomach), HEADACHE (severe headache) and CHILLS (chills) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (The patient contracted the COVID-19 virus on 03 Jan 2021 and recovered approximately two or three weeks later) from 03-Jan-2021 to January 2021.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced ILLNESS (very sick), DIZZINESS (dizziness), ABDOMINAL DISCOMFORT (upset stomach), HEADACHE (severe headache), CHILLS (chills) and PYREXIA (on a heating pad but his temperature is normal). At the time of the report, ILLNESS (very sick), DIZZINESS (dizziness), ABDOMINAL DISCOMFORT (upset stomach), HEADACHE (severe headache), CHILLS (chills) and PYREXIA (on a heating pad but his temperature is normal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. List of concomitant medication were not given.
4YO was given Boostrix instead of Infanrix; 4YO was given Boostrix; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 4-year-old patient who received DTPa (Reduced antigen) (Boostrix) (batch number 92K5T, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   Additional Information: GSK receipt date: 20-Dec-2022 Reporter's comment: Only lot number was provided by health care professional, the reporter was unable to provide additional details.  LOT number shows no results when searched from Medical information screen.  Adverse event contains all reported information. The reporter gave consent for safety team follow up.  The reporter consented to follow-up. Additional supportive information: The patient received Boostrix instead of Infanrix at inappropriate age, which led to wrong vaccine administered and inappropriate age at vaccine administration.
This spontaneous report was received from a physician's assistant via company representative and refers to a 36 year old female patient. No medical history or concurrent conditions were reported. On 18-FEB-2015, the patient was vaccinated with PNEUMOVAX 23 through an unspecified route (dose and route were not reported). Other suspect product initiated on the same day included unspecified flu vaccine which was administered in the same arm as PNEUMOVAX 23. No concomitant medications were reported. On 19-FEB-2015, the patient experienced swelling around the injection site, vomiting and was unable to keep anything down, fever of 102 F, arm was swollen, tight and red. Hence the physician's assistant recommended the patient to visit an emergency room, (ER) on 20-FEB-2015. The patient sought medical attention with physician's assistant by texting back and forth via cellular phone. On an unknown date, the patient's white blood count was 1900. The outcome of the events was unknown. The reporter did not assess the events with pneumococcal vaccine, polyvalent (23-valent). No other information was available. Additional information has been requested.
When seeing this patient, I saw the child profile and saw that it said Meningococcal but didn?t see the year and thought that this was his first, but it wasn?t turns out that it was his second. I did notify parent already and she knows about the incident and Dr. is aware as well. Gave MenQuadfi NDC 4928159058 exp: 02/28/2026 lot:U7938AB. This will not count in System since he needed to be 16 yrs of age.
Developed urticarial lesions of face later around the injection site, given Benadryl IM and after 5-10 minutes, rash started fading. Given Rx for Benadryl and Prednisolone and told to take to emergency if gets worse.
My husband developed sclerosis of the live followed by a heart attach and then kidney failure.  My husband was complaining about feeling exhausted and ache all over.  He fell the following day and was transported to the emergency room on 8/5/2021 and admitted later that day.  My husband never left the hospital and passed away on 8/11/2021.
PT RECEIVED HPV#1 LAST AND THEN BECAME VERY PALE AND STATED HE FELT LIGHT HEADED. PT THEN FAINTED WHILE SITTING IN THE CHAIR AND HIS HEAD FELL FORWARD. PT WAS STABILIZED BY 2 NURSES AND WHEN HIS HEAD WAS LIFTED UP HIS EYES WERE ROLLED BACK IN HIS HEAD, HE WAS DROOLING AND MAKING "SNORING" SOUNDS AND THEN STARTED SHAKING.
Gave 0.5ml dose instead of the 0.25ml dose for the 3rd dose.
Body Aches - random spots on the body starts hurt, mostly joint areas AND MUSCLES Chills - my sense of heat was mostly gone. I felt cold under heavy blanket. I took a hot shower, but the highest setting (111*F) felt lukewarm.